I note Dendreon has 125 mil shares cf Prima @ very roughly 600 mil. This gives a ballpark of US$6 per PRR share if no further dilution.
If the PRR patented process for cancer can be successfully applied to other cancers....well....who knows what value these shares have.
I see the timetable for 'results to market' may be over 2 years. Deals with other parties no doubt would be more fruitful (read valuable) the more 'proven' the treatment.
Therefore PRR seems to be a longer term hold at this stage to realise it's optimum return over a time frame.
Can anyone shed some light on the above points. I realise a lot is guesswork at this stage.
I wouldn't mind some more definitive information on PRR beyond their announcements. Anyone????
welcome to new holders, page-12
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.015(4.41%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $1.270M | 3.611M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 286261 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 253490 | 7 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |